, Tracking Stock Market Picks
Enter Symbol:
Bristol-myers Squibb Company (BMY) [hlAlert]

Equal Weight
up 8.60 %

Bristol-myers Squibb Company (BMY) rated Equal Weight with price target $70 by Barclays

Posted on: Tuesday,  Dec 1, 2015  1:25 PM ET by Barclays

Barclays rated Equal Weight Bristol-myers Squibb Company (NYSE: BMY) on 12/01/2015. Previously Barclays rated Overweight Bristol-myers Squibb Company (NYSE: BMY) on
01/10/2014., when the stock price was $56.00. Since then, Bristol-myers Squibb Company has gained 8.61% as of 12/01/2015's recent price of $60.82.
If you would have followed the previous Barclays's recommendation on BMY, you would have gained 8.6% of your investment in 690 days.

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/1/2015 1:25 PM Buy
67.91 70.00
as of 8/27/2015
1 Week down  -3.01 %
1 Month down  -9.66 %
3 Months down  -9.82 %
1 YTD up  8.60 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/10/2014 1:25 PM Buy
56.00 65.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy